title: [Acute disseminated lupus erythematosus. Responsibility of Corenitec: apropos of a case].
authors.forename: N
authors.initials: N
authors.lastname: Rosenfeld
authors.forename: S
authors.initials: S
authors.lastname: Yeche
authors.forename: D
authors.initials: D
authors.lastname: Reynaud
authors.forename: L
authors.initials: L
authors.lastname: Abiad
authors.forename: A
authors.initials: A
authors.lastname: Dubois
mesh_terms: D000368:Aged; D000974:Antibodies, Antinuclear / Q000097:blood; D000918:Antibody Specificity; D000959:Antihypertensive Agents / Q000009:adverse effects*; D001327:Autoimmune Diseases / Q000139:chemically induced* / Q000276:immunology; D004247:DNA / Q000276:immunology; D004338:Drug Combinations; D004656:Enalapril / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006657:Histones / Q000276:immunology; D006801:Humans; D006852:Hydrochlorothiazide / Q000008:administration & dosage / Q000009:adverse effects*; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000276:immunology
chemical_list: D000974:Antibodies, Antinuclear; D000959:Antihypertensive Agents; D004338:Drug Combinations; D006657:Histones; D006852:Hydrochlorothiazide; D004656:Enalapril; D004247:DNA